Neuroinflammation-targeted magnetic resonance imaging nanoprobes for the early diagnosis of Alzheimer's disease
Source abstract
Abstract
Alzheimer's disease (AD) that is an important contributor to dementia, is a chronic and irreversible neurodegenerative disease, with high rates of disability and mortality. Recently, more and more therapeutic methods have been developed to delay the progression of AD, but it remains a great challenge to achieve the early diagnosis of AD. In this work, we developed a magnetic resonance imaging (MRI) nanoprobe (NP@angiopep-2/CD137) based on angiopep-2 peptide and CD137 antibody with a NaGdF4 nanoparticle as the core and realized neuroinflammation-targeted imaging on APP/PS1 model mice using a clinical 7.0 T MRI scanner. CD137 expression was upregulated in neuroglial cells and cerebral vascular endothelial cells in inflammatory state. In the APP/PS1 mouse model, after administration, the nanoprobe-enhanced images showed specific dot-like signals in the susceptibility-weighted imaging (SWI) sequence. In summary, we designed and synthesized NP@angiopep-2/CD137 nanoprobes using the activation-dependent expression of CD137, which were applied to the pathological assessment of AD based on the hypothesis of AD neuroinflammation, and provided a reliable idea for the early molecular imaging diagnosis of AD.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China
Funding
National Natural Science Foundation of China
References (52)
Show source-provided references
1. Alzheimer’s Dementia , 2023 , 19 , 15981695
2. Prince · World Alzheimer Report 2014: Dementia and Risk Reduction. An Analysis of Protective and Modifiable Factors · 2014
3. Mattke · J. Prev. Alzheimer's Dis. · 2024 · 11 · 30310.14283/jpad.2024.23 ↗
4. Jia · Lancet Public Health · 2020 · 5 · e66110.1016/S2468-2667(20)30185-7 ↗
5. Ren · Gen. Psychiatry · 2022 · 35 · e10075110.1136/gpsych-2022-100751 ↗
6. McKhann · Neurology · 1984 · 34 · 93910.1212/WNL.34.7.939 ↗
7. Khan · Curr. Neuropharmacol. · 2020 · 18 · 110610.2174/1570159X18666200528142429 ↗
8. Donohue · JAMA · 2017 · 317 · 230510.1001/jama.2017.6669 ↗
9. McKhann · Alzheimer's Dementia · 2011 · 7 · 26310.1016/j.jalz.2011.03.005 ↗
10. Albert · Alzheimer's Dementia · 2011 · 7 · 27010.1016/j.jalz.2011.03.008 ↗
11. Jack · Nat. Med. · 2024 · 30 · 212110.1038/s41591-024-02988-7 ↗
12. Parekh · WIREs Nanomed. Nanobiotechnol. · 2024 · 16 · e194610.1002/wnan.1946 ↗
13. Ossenkoppele · Brain · 2015 · 138 · 273210.1093/brain/awv191 ↗
14. Zhang · Nat. Commun. · 2023 · 14 · 614910.1038/s41467-023-41783-9 ↗
15. Li · Front. Cell. Neurosci. · 2016 · 10 · 269
16. Morales · Front. Cell. Neurosci. · 2014 · 8 · 112
17. Quinn · J. Neuroimmunol. · 2003 · 137 · 3210.1016/S0165-5728(03)00037-7 ↗
18. Guo · Molecules · 2022 · 27 · 708010.3390/molecules27207080 ↗
19. Wang · CNS Neurosci. Ther. · 2021 · 27 · 52810.1111/cns.13619 ↗
20. Castellani · Science · 2023 · 380 · eabo764910.1126/science.abo7649 ↗
21. Hanzel · Neurobiol. Aging · 2014 · 35 · 224910.1016/j.neurobiolaging.2014.03.026 ↗
22. Choi · Nat. Cell Biol. · 2023 · 25 · 96310.1038/s41556-023-01158-0 ↗
23. Xie · Aging-Us · 2020 · 12 · 22538
24. Xu · Mol. Neurobiol. · 2016 · 53 · 670910.1007/s12035-015-9593-4 ↗
25. Schwab · J. Alzheimer's Dis. · 2008 · 13 · 35910.3233/JAD-2008-13402 ↗
26. Koudrina · ACS Omega · 2020 · 5 · 2269110.1021/acsomega.0c02650 ↗
27. Salarian · Wiley Interdiscip. Rev.:Nanomed. Nanobiotechnol. · 2020 · 12 · e1622
28. Jin · Methods Mol. Biol. · 2021 · 2282 · 19510.1007/978-1-0716-1298-9_13 ↗
29. Mikhaylov · Cancers · 2022 · 14 · 402610.3390/cancers14164026 ↗
30. Tang · Biomater. Sci. · 2021 · 9 · 524710.1039/D1BM00566A ↗
31. Zapata-Acevedo · PLoS One · 2024 · 19 · e030203110.1371/journal.pone.0302031 ↗
32. Sun · Front. Neurosci. · 2024 · 18 · 142873610.3389/fnins.2024.1428736 ↗
33. Chen · Adv. Mater. · 2023 · 36 · 231040410.1002/adma.202310404 ↗
34. Söderström · Atherosclerosis · 2018 · 272 · 6610.1016/j.atherosclerosis.2018.03.007 ↗
35. Ye · Cancer Sci. · 2020 · 111 · 146110.1111/cas.14354 ↗
36. Dharmadhikari · OncoImmunology · 2016 · 5 · e111336710.1080/2162402X.2015.1113367 ↗
37. Kwon · Immune network · 2009 · 9 · 8410.4110/in.2009.9.3.84 ↗
38. Vinay · Cell Mol. Immunol. · 2011 · 8 · 28110.1038/cmi.2010.82 ↗
39. Curto · Neurochem. Int. · 2004 · 44 · 38110.1016/j.neuint.2003.08.012 ↗
40. Wong · Front. Immunol. · 2020 · 11 · 57196410.3389/fimmu.2020.571964 ↗
41. Zang · J. Geriatr. Cardiol. · 2023 · 20 · 22310.26599/1671-5411.2023.03.004 ↗
42. Ising · Nature · 2019 · 575 · 66910.1038/s41586-019-1769-z ↗
43. Olofsson · Circulation · 2008 · 117 · 129210.1161/CIRCULATIONAHA.107.699173 ↗
44. Hou · ACS Nano · 2013 · 7 · 33010.1021/nn304837c ↗
45. Rondon · Int. J. Nanomed. · 2020 · 15 · 618310.2147/IJN.S252397 ↗
46. Watamura · Neurochem. Int. · 2022 · 158 · 10536110.1016/j.neuint.2022.105361 ↗
47. Flood · Neurobiol. Aging · 2002 · 23 · 33510.1016/S0197-4580(01)00330-X ↗
48. Webster · Alzheimer's Res. Ther · 2013 · 5 · 2810.1186/alzrt182 ↗
49. Haller · Radiology · 2021 · 299 · 310.1148/radiol.2021203071 ↗
50. Qiao · ACS Nano · 2012 · 6 · 330410.1021/nn300240p ↗
51. Ivask · Biomater. Sci. · 2018 · 6 · 31410.1039/C7BM01012E ↗
52. Zhu · CNS Neurosci. Ther. · 2017 · 23 · 31010.1111/cns.12677 ↗